Clinical trial
Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis…
NCT00352599 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00352599 |
|---|---|
| Title | Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1) |
| Official title | Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1) |
| Acronym | NF1 |
| Lead sponsor | University of California, Los Angeles, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neurofibromatosis 1 |
| Intervention type | Drug |
| Interventions | Lovastatin, placebo pill |
| Enrollment | 44 |
| Start date | Sep 1, 2009 |
| Primary completion | Mar 1, 2014 |
| Completion | Mar 1, 2014 |
| First posted | Jul 14, 2006 |
| Last update posted | Nov 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: